Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer

被引:0
|
作者
Li, Kunlin [1 ]
Li, Lin [1 ]
Xie, Xiyue [1 ]
Zhu, Jing [1 ]
Xia, Daqing [1 ]
Xiang, Lunli [1 ]
Cai, Kaiyong [1 ]
Zhang, Jixi [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, 174 Shazheng St, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor immunotherapy; Responsive self-assembly; Photoacoustic effects; Lysosomal membrane permeabilization; Endoplasmic reticulum stress; THERAPY;
D O I
10.1016/j.actbio.2024.08.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although immunogenic cell death (ICD) induced by lysosomal membrane permeabilization (LMP) evidently enhance the effectiveness of antitumor immunity for triple-negative breast cancer (TNBC) with poor immunogenicity, their potential is increasingly restricted by the development of other death pathways and the repair of lysosomes by endoplasmic reticulum (ER) during LMP induction. Herein, a poly- dopamine nanocomposite with i-motif DNA modified and BNN6 loaded is prepared toward boosting LMP and immunotherapy of TNBC by synergy of spatially confined photoacoustic (PA) effects and nitric oxide. Combining the high-frequency pulsed laser (40 0 0 kHz) with the intra-lysosomal assembly of nanocomposites produced spatially confined and significantly boosted PA effects (4.8-fold higher than the individually dispersed particles extracellular), suppressing damage to other cellular components and selectively reducing lysosomal integrity to 19.2 %. Simultaneously, the releasing of nitric oxide inhibited the repair of lysosomes by ER stress, causing exacerbated LMP. Consequently, efficient immune activation was achieved, including the abundant releasing of CRT/HMGB1 (5.93-6.8-fold), the increasing maturation of dendritic cells (3.41-fold), and the fostered recruitment of CD4+/CD8+ T cells (3.99-3.78-fold) in vivo . The study paves a new avenue for the rational design and synergy of confined energy conversion and responsive nanostructures to achieve the treatment of low immunogenicity tumors.
引用
收藏
页码:381 / 395
页数:15
相关论文
共 50 条
  • [1] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [2] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [3] Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells
    Wooten, Jonathan
    Mavingire, Nicole
    Araujo, Cristina A.
    Aja, Joyce
    Wauchope, Shaniece
    Delgoda, Rupika
    Brantley, Eileen
    FITOTERAPIA, 2022, 160
  • [4] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [5] Immunotherapy in triple-negative breast cancer
    Heather Katz
    Mohamed Alsharedi
    Medical Oncology, 2018, 35
  • [6] The Use of Immunotherapy in Triple-Negative Breast Cancer
    Schmid, Peter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 770 - 773
  • [7] Advances in immunotherapy for triple-negative breast cancer
    Yang Liu
    Yueting Hu
    Jinqi Xue
    Jingying Li
    Jiang Yi
    Jiawen Bu
    Zhenyong Zhang
    Peng Qiu
    Xi Gu
    Molecular Cancer, 22
  • [8] Role of Immunotherapy in Triple-Negative Breast Cancer
    Keenan, Tanya E.
    Tolaney, Sara M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (04): : 479 - 489
  • [9] Prospects of Immunotherapy for Triple-Negative Breast Cancer
    Qiu, Dan
    Zhang, Guijuan
    Yan, Xianxin
    Xiao, Xinqin
    Ma, Xinyi
    Lin, Shujun
    Wu, Jieyan
    Li, Xinyuan
    Wang, Wandi
    Liu, Junchen
    Ma, Yi
    Ma, Min
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [10] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
    Savas, Peter
    Loi, Sherene
    CANCER CELL, 2020, 37 (05) : 623 - 624